NextCell Pharma AB Employee Directory
Biotechnology ResearchStockholm, Sweden11-50 Employees
NextCell Pharma AB is a biotechnology research company based in Huddinge, Stockholm, Sweden. It focuses on developing advanced therapies for autoimmune diseases and transplantation, building on collaborations that bring together expertise in cord blood–derived cells and autoimmune disease research. The company’s lead product, ProTrans, is being evaluated through clinical trials that began in November 2018, reflecting its aim to address therapeutic needs in autoimmune conditions. NextCell operates within the biotechnology sector as a developer of mesenchymal stem cell–related approaches, pursuing partnerships and research collaborations to advance its early-stage portfolio. The organization is part of a broader ecosystem that includes Cellaviva and Diamyd Medical, contributing to its positioning in Sweden’s biotech landscape. Recent activity includes a collaboration with FUJIFILM Corporation to launch a research-use platform for mesenchymal stromal cell research, illustrating its ongoing efforts to expand its capabilities and partnerships in the field.